Directed evolution is a useful tool in the study of enzymes. It is used in this study to investigate the means by which resistance to the antibiotic trimethoprim develops in dihyrofolate reductase from Escherichia coli. Mutants with clinical levels of resistance were obtained after only three generations. After four generations of directed evolution, several mutants were characterized, along with some point mutants made to investigate amino acid changes of interest. Several mutations were found to grant resistance to trimethoprim, both by reducing the binding affinity of the enzyme for the drug, and by increasing the activity of the enzyme
Dihydrofolate reductase (DHFR) is a ubiquitous enzyme with an essential role in cell metabolism. DHF...
BACKGROUND: Trimethoprim resistance is increasing in Enterobacteriaceae. In 2004-2006 an interventio...
Antibiotic development is frequently plagued by the rapid emergence of drug resistance. However, ass...
Resistant strains for trimethoprim, a potent inhibitor of dihydrofolate reductase, were obtained by ...
Summary. The effect of plasmid pUKll23, which confers low level resistance to trimethoprim when test...
Antibiotic resistance is a worldwide challenge. A potential approach to block resistance is to simul...
Trimethoprim resistance in the Enterobacteriaceae has been dominated by the spread of two genes enco...
Although enzymes are the product of millions of years of natural evolution, their properties are fre...
Since the fIrst site directed mutagenesis in the mid 1980s, protein engineering has become a very po...
Evolutionary fitness landscapes of several antibiotic target proteins have been comprehensively mapp...
Fitness landscapes of drug resistance constitute powerful tools to elucidate mutational pathways of ...
Evolutionary fitness landscapes of several antibiotic target proteins have been comprehensively mapp...
Mutators may present an enhanced risk for the emergence of antibiotic resistance in bacteria during ...
Trimethoprim is a synthetic antibacterial agent that targets folate biosynthesis by competitively bi...
During the last decades, a continuous rise of multi-drug resistant pathogens has threatened antibiot...
Dihydrofolate reductase (DHFR) is a ubiquitous enzyme with an essential role in cell metabolism. DHF...
BACKGROUND: Trimethoprim resistance is increasing in Enterobacteriaceae. In 2004-2006 an interventio...
Antibiotic development is frequently plagued by the rapid emergence of drug resistance. However, ass...
Resistant strains for trimethoprim, a potent inhibitor of dihydrofolate reductase, were obtained by ...
Summary. The effect of plasmid pUKll23, which confers low level resistance to trimethoprim when test...
Antibiotic resistance is a worldwide challenge. A potential approach to block resistance is to simul...
Trimethoprim resistance in the Enterobacteriaceae has been dominated by the spread of two genes enco...
Although enzymes are the product of millions of years of natural evolution, their properties are fre...
Since the fIrst site directed mutagenesis in the mid 1980s, protein engineering has become a very po...
Evolutionary fitness landscapes of several antibiotic target proteins have been comprehensively mapp...
Fitness landscapes of drug resistance constitute powerful tools to elucidate mutational pathways of ...
Evolutionary fitness landscapes of several antibiotic target proteins have been comprehensively mapp...
Mutators may present an enhanced risk for the emergence of antibiotic resistance in bacteria during ...
Trimethoprim is a synthetic antibacterial agent that targets folate biosynthesis by competitively bi...
During the last decades, a continuous rise of multi-drug resistant pathogens has threatened antibiot...
Dihydrofolate reductase (DHFR) is a ubiquitous enzyme with an essential role in cell metabolism. DHF...
BACKGROUND: Trimethoprim resistance is increasing in Enterobacteriaceae. In 2004-2006 an interventio...
Antibiotic development is frequently plagued by the rapid emergence of drug resistance. However, ass...